TradingView
PlanTradePlanMM
14 de Jun. de 2021 22:41

EVOK Long Largo

Evoke Pharma, Inc.NASDAQ

Descripción

Price above SMA13
OBV>OBV34
WR > -80

Entry 1.4
Stop 1
Target 3.7

Risk management is much more important than a good entry point.
The max Risk of each plan should be less than 1% of an account.
I am not a PRO trader. I trade option to test my trading plan with small cost.

Operación activa

BuyToOpen (BTO) 2022 C2.5 0.3x10
Prepare to sell C5
No Stop
Más